BestBrain
Cognitive Self-care Solutions
Startup Seed Health Tech & Life Sciences Est. 2016
Total Raised
Undisclosed
Seed
Last Round
Undisclosed
2 rounds
Investors
1
1 public
Team
2
1-10 employees
Confidence
85/100
About
BestBrain is developing a noninvasive, personalized brain therapy that aims to improve patients' lives and stop the progression of dementia by training the brain to change itself. The company's current focus is on patients in the early phase of Alzheimer's disease with mild cognitive impairment who struggle with memory loss. The therapy is user friendly, simple, and affordable to implement, and has the potential to be highly effective. The therapy is a cinema experience that allows clients to watch any movie or television show from the comfort of their own couch while wearing a custom-designed headset. It works anywhere the patient can comfortably sit and watch a movie, and doesn't require traveling to a clinic. The company is also building a large-scale database of brain activity recordings of patients experiencing the onset of dementia. It is developing a machine-learning system to find biomarkers of dementia so that it can help create early detection tools that could ultimately allow doctors to treat patients earlier and more effectively. The company is also developing a product that will improve the lives of children with autism spectrum disorders.
Classification
Sector
Health Tech & Life SciencesDigital HealthcareDigital Therapeutics
Core Technology
Platforms & InterfacesSoftwareArtificial IntelligenceMachine LearningSemiconductors & ElectronicsWearables
Target Customer
ConsumersDemographics & FamilyDisabilitiesChildrenHealthcare & Life SciencesHealthcarePatientsProviders
Business Model
B2CB2B
Tags
personalizationdisabilitieschildrenbiomarkersbrain-disordermachine-learningdigital-therapeuticsalzheimers-diseaseearly-detectionnon-invasivedigital-healthcarewearablesoftware-applicationsartificial-intelligenceautismhome-care
Funding & Events
Jan 2019
Non-equity Undisclosed
Israel Innovation Authority
Feb 2018
Seed Undisclosed
China Israel Biology (CIB)
Details
Product Stage
Clinical Trial
Employees
1-10
Exact Count
3
District
Center District
Founded
2016
Registrar
515713246
Locations
HaBarzel Street 30, Tel Aviv-Yafo, Israel
Links
Website
LinkedIn
Admin
Last Update
Dec 13, 2021
Verified by
Yotam Maman
Missing
news, not claimed, video or image
Team (2)
Paul Nurflus
Co-founder & CEO
Founder
Dr. Doron Todder
CMO
Internal
Created by
Yotam Maman (yotamm1988@gmail.com)
Created
2021-12-02T00:00:00.000Z
Last editor
Yotam Maman (yotamm1988@gmail.com)